Search Results
-
FILTER BY DATEAll Time
-
-
FILTER BY RELEVANCEMost Relevant
-
-
FILTER BY CONTENT TYPEAll Content Types
-
American Enterprise Institute (AEI) president Arthur C. Brooks has announced that AEI scholar Leon R. Kass, M.D., is the recipient of AEI’s 2012 Irving Kristol Award. Dr. Kass will receive the award and deliver the Irving Kristol Lecture at AEI’s annual dinner on Wednesday, May 2, 2012, at the National Building Museum in Washington, D.C.
The crisis in financing is having a chilling effect on biomedical innovation. As discussed in my last column, the main problem in our industry is that the sheer cost of drug development has become almost prohibitively expensive, effectively pricing almost everyone but the largest companies out of the market.
Successfully translating scientific discoveries requires a sense of urgency, which some disease foundations seem to have, and many big pharmas appear to need. Patients waiting expectantly for medical research to produce important new cures are finding bad news almost everywhere they turn.
For the last decade, as the biopharmaceutical industry has struggled — largely unsuccessfully — to live up to its anticipated potential, a litany of experts, analysts, participants, and commentators have offered up their diagnosis and treatment for pharma’s productivity problem.
The basic question they’re all trying to solve: how can...
"We are at the cusp of a revolution in medicine and biotechnology," Sonia Arrison announces in "100+", "that will radically increase not just our life spans but also, and more importantly, our health spans." This revolution will "change everything, from careers and relationships to family and faith."
Improving healthcare will require increased focus on the gap between the clinical practice of medicine and health as it's experienced in real life.
AEI contributorsfrom the federal government, foundation sector, and the nation's top scientists seek to define the major issues in ensuring continued U.S. leadership in biomedical research.
Genetically engineered animals embody an innovative technology that is transforming public health through biomedical, food, and environmental applications.







